Liquid biopsy for testicular cancer
Part of Cancer clinical trials.
This study tests whether a liquid biopsy (a simple blood test) can help monitor germ cell tumors (a type of testicular cancer) that have spread or have a high risk of coming back. It may help guide treatment decisions without needing repeated tissue biopsies.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Must be male and 18 years or older
- Diagnosed with seminoma or non-seminoma germ cell tumor (including extragonadal origin)
- Cancer has spread to other parts of the body (metastatic disease)
- Or have stage I seminoma with at least one risk factor (rete testis invasion or tumor larger than 4 cm) and choose active surveillance
- No other cancer in the last 5 years (except germ cell tumors)
- Stage I patients cannot have received adjuvant treatment
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a blood test called miRNA-371 can detect active germ cell tumors in patients who have had surgery or are being watched. It may help guide treatment decisions without needing extra biopsies or scans.
This trial looks for signs of cancer DNA in your blood (circulating tumor DNA) to see if it can help track germ cell tumors. It may help doctors find out if your cancer is coming back earlier.
This study looks at using a simple blood test (liquid biopsy) to read tumor DNA and understand how it could affect treatment decisions. It is for adults with metastatic prostate cancer who are about to start, are receiving, or recently finished treatment.
This study collects blood and may also use existing tumor tissue to help develop a liquid biopsy blood test for people with solid (non-blood) cancers. You may qualify if you have a current cancer with tumor in the body and can provide blood samples at set visits.
This trial uses a robot and a special dye (ICG) to find and remove the first lymph node that might contain cancer cells in men with testicular cancer. It aims to reduce unnecessary lymph node removal while still detecting spread.
This study looks at how a “liquid biopsy,” a test done on blood, may help in people with mature B-cell tumors. It mainly checks whether you can take part and complete the planned study procedures.
Hear when a new 100 Stage I Patients trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.